You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for AstraZeneca AB v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

AstraZeneca AB v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket	⤷ Sign Up	Date Filed	2018-10-26
Court	District Court, D. Delaware	Date Terminated	2019-12-03
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To
Parties	ASTRAZENECA PHARMACEUTICALS LP
Patents	10,166,247; 7,759,328; 7,967,011; 8,143,239; 8,575,137
Attorneys	Daniel M. Silver
Firms	Shaw Keller LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in AstraZeneca AB v. Teva Pharmaceuticals USA, Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for AstraZeneca AB v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2018-10-26	1		expiration of U.S. Patent Nos. 7,759,328 (“the ’328 patent”), 8,143,239 (“the ’239 patent”), 8,575,137 (“… The Patents-in-Suit 8. United States Patent No. 7,759,328 (“the ’328 patent”), entitled…of the ’328 patent. 10. United States Patent No. 8,143,239 (“the ’239 patent”), entitled…of the ’137 patent. 14. United States Patent No. 7,967,011 (“the ’011 patent”), entitled… This is a civil action for patent infringement arising under the patent laws of the United States,	External link to document
2019-12-02	116	Consent Judgment - Proposed	United States Patent Numbers 7,759,328, 8,143,239, 8,575,137, 7,967,011, and 10,166,247, on its own part…2018 4 December 2019 1:18-cv-01685 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-12-03	117	SO ORDERED	United States Patent Numbers 7,759,328, 8,143,239, 8,575,137, 7,967,011, and 10,166,247, on its own part…2018 4 December 2019 1:18-cv-01685 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-12-03	118	Patent/Trademark Report to Commissioner of Patents	,143,239; 8,575,137; 7,967,011; 10,166,247. (Attachments: # 1 Consent Judgment)(nmf) (Entered: 12/04/2019… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328; 8,143,239…2018 4 December 2019 1:18-cv-01685 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-05-31	35	Patent/Trademark Report to Commissioner of Patents	,143,239 ;8,575,137 ;7,967,011 ;10,166,247 . (Silver, Daniel) (Entered: 05/31/2019) 31 May 2019 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328 ;8,143,239…2018 4 December 2019 1:18-cv-01685 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.